Price T Rowe Associates Inc Mersana Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 99,078 shares of MRSN stock, worth $200,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,078

Previous 79,932 23.95%

Holding current value

$200,137

Previous $359,000 44.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $38,292 - $85,199	19,146 Added 23.95%	99,078 $200,000
Q1 2024 May 15, 2024	BUY	$2.16 - $5.94 $10,717 - $29,474	4,962 Added 6.62%	79,932 $359,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $13,478 - $28,414	-12,143 Reduced 13.94%	74,970 $174,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $34,165 - $126,027	-32,232 Reduced 27.01%	87,113 $111,000
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $6,258 - $19,405	-2,032 Reduced 1.67%	119,345 $394,000
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $3,432 - $6,023	858 Added 0.71%	121,377 $500,000
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $47,912 - $66,652	8,480 Added 7.57%	120,519 $707,000
Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $128,621 - $222,240	-27,780 Reduced 19.87%	112,039 $758,000
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $5,069 - $8,925	1,785 Added 1.29%	139,819 $646,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $88,215 - $156,381	23,587 Added 20.61%	138,034 $551,000
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $4.75 Million - $8.54 Million	-866,449 Reduced 88.33%	114,447 $712,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $11.4 Million - $19.3 Million	-1,336,851 Reduced 57.68%	980,896 $9.25 Million
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $8.72 Million - $11.9 Million	-656,340 Reduced 22.07%	2,317,747 $31.5 Million
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $5.06 Million - $8.76 Million	-330,259 Reduced 9.99%	2,974,087 $48.1 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $55.6 Million - $91.2 Million	3,304,346 New	3,304,346 $87.9 Million

Others Institutions Holding MRSN

# of Institutions

124

Shares Held

114M

Call Options Held

73.5K

Put Options Held

46.4K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $196M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Mersana Therapeutics, Inc. Transaction History